Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Mount Sinai Medical Center marked a significant milestone yesterday with the Topping Out ceremony for the new Irma and Norman Braman Comprehensive Cancer Center, located on its main campus in Miami ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
Hosted on MSN2d
Easy Spirit Supports Women's Heart Health With ‘Move for Heart' Campaign Aiding Mount Sinai HospitalAmid National Heart Health Month, Easy Spirit has announced its "Move for Heart" initiative, teaming up with the Mount Sinai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback